Developer docs
API playgroundTry for free, no card

Search company profiles

Dasa

Full company profile

uuid0008eug

Namestring
Dasa
Legal namestring
Dasa
Websiteurl
dasa.com.br
Company typeenum
Public
Founded yearint
2023
Descriptiontext

Dasa operates Brazil's largest integrated diagnostic medicine network and is positioned as the largest laboratory network in Latin America. The company runs 850+ diagnostic units under 40+ regional brands (including Delboni, Lavoisier, Sérgio Franco, Bronstein, Alta Diagnósticos, and others) and processes more than 400 million examinations annually in partnership with 350,000+ physicians, serving over 20 million patients per year. Beyond diagnostics, the business spans hospital care (Hospital São Domingos, Hospital da Bahia, Hospital Paraná, Grupo São Camilo), oncology (Dasa Oncologia, Amo, Onco Centro, Onco Hematos), genomic medicine (Dasa Genômica), and care management (Dasa Gestão de Cuidados), with a digital patient platform (Nav Dasa) consolidating scheduling, teleconsultations, and medical history across all brands.

Short descriptiontext

Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ units under 40+ brands and serving 20M+ patients and 350,000+ physicians annually across lab, imaging, hospital, oncology, and genomic services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic medicine services, clinical laboratory testing, medical imaging diagnostics, genomic testing services, corporate occupational health
Industry2 codes
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Medical Laboratories621511
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Medicine and Healthcare Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Diagnostic Services
TypeTransaction Fee
Description

Laboratory diagnostic services including clinical analysis, imaging, and genetic testing across 850+ units throughout Brazil.

dasa.com.br
2Hospital and Oncology Services
TypeTransaction Fee
Description

Hospital care and oncology treatment services with 15% revenue growth in 2023 compared to previous year.

dasa.com.br
3Dasa +Saúde Subscription Card
TypeSubscription Recurring
Description

Annual subscription card offering discounts on consultations, exams, vaccines, and medications with monthly payment options (R$9.90-19.90/month).

dasa.com.br
4Corporate Health Solutions
TypeProfessional Services
Description

B2B services including occupational health exams, toxicology testing, executive check-ups, and vaccination programs for corporate clients.

dasa.com.br
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details2 tiers
1Basic plan with essential health discounts
ModelSubscriptionBilling cadenceMonthly
Notes

R$9.90/month - includes medications discount up to 70%, nutritionist and psychologist discounts up to 50%, tele-specialties, unlimited tele-emergency care, up to 4 dependents included, in-person consultations at accessible prices, laboratory exams with up to 50% discount, vaccines with up to 10% discount.

dasa.com.br
2Plus plan with enhanced discount benefits
ModelSubscriptionBilling cadenceMonthly
Notes

R$19.90/month - includes nutritionist and psychologist discounts up to 50%, laboratory exams with up to 60% discount, vaccines with up to 15% discount, surgical packages with up to 10% discount.

dasa.com.br
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Cartão Dasa +Saúde
Description

A health benefits card offering discounts on consultations, exams, vaccines, and medications with annual subscription plans starting at R$9.90/month.

dasa.com.br
Core offering1 text field

Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ laboratory and imaging units under 40+ regional brands that process over 400 million examinations annually. The company offers clinical laboratory tests, diagnostic imaging, genomic testing (Dasa Genômica), oncology care (Dasa Oncologia), hospital services, and corporate occupational health solutions, complemented by the Nav Dasa digital platform for appointments and teleconsultations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 20 million+ patients served annually
+3 more records
Product overview1 text field

Dasa is Brazil's largest integrated healthcare network, operating as a platform combining multiple diagnostic medicine brands and healthcare services. The core offering includes the Dasa diagnostic medicine network with 850+ laboratory and imaging units, complemented by specialized verticals including Dasa Genômica (genomic testing), Dasa Oncologia (cancer care), and hospital/care management services. Digital access is provided through Nav Dasa platform for appointments and medical records, while the Cartão Dasa +Saúde membership program offers discounted healthcare services. Additional services include clinical research, medical education (Dasa Educa), vaccination programs, and home healthcare visits. The company operates through 40+ regional brands across Brazil including Delboni, Lavoisier, Sérgio Franco, Bronstein, and many others.

Product and service12 records
1Dasa - Rede de Medicina Diagnóstica
CategoryDiagnostic Medicine Services
Description

Brazil's largest integrated diagnostic medicine network offering laboratory tests, imaging services, and clinical analysis across 850+ locations throughout Brazil, processing over 400 million tests annually in partnership with 350,000+ physicians. Serves individual patients and corporate clients with routine and specialized diagnostic services.

2Nav Dasa
3Dasa Genômica
CategoryGenomic Testing Services
Description

Specialized genomics laboratory focused on personalized medicine, offering genetic testing for diagnosis, prognosis, and treatment guidance across multiple medical specialties including oncology, endocrinology, and neurology. For physicians, patients, and clinical researchers.

4Dasa Oncologia
CategoryOncology Care Services
Description

Oncology care service dedicated to ensuring each person in treatment receives appropriate and personalized care, providing comprehensive cancer treatment management. For cancer patients across Brazil.

5Dasa Hospitais e Cuidados Integrados
CategoryHospital Services
Description

Hospital network and integrated care management company with multidisciplinary teams accompanying patients across all stages from prevention to treatment. Includes hospitals such as Hospital da Bahia, Hospital São Domingos, and Grupo São Camilo.

6Cartão Dasa +Saúde
CategorySubscription Healthcare Benefits Program
Description

Health benefits discount card offering real discounts on consultations, exams, vaccines, and medications with monthly subscriptions starting at R$9.90 (Basic) or R$19.90 (Plus), covering over 40 medical specialties with national reach. For individuals, families, and corporate clients seeking affordable healthcare access.

7Dasa Pesquisa Clínica
CategoryClinical Research Services
Description

Clinical research division organized into three verticals with hundreds of professionals acting as investigators in medical research studies, with over 1,000 studies published by February 2024.

8NAM – Núcleo de Assessoria Médica
CategoryPhysician Advisory Services
Description

Medical advisory center providing support services for physicians including continuing education, clinical guidance, and practice management support. For partner physicians and medical specialists across Brazil.

9Dasa Educa
10Dasa Vacinas
CategoryVaccination Services
Description

Vaccination services available for individual patients, physicians, and corporate clients, including home vaccination appointments. For individual patients, families, and corporate employee wellness programs.

11Atendimento Domiciliar
CategoryHome Healthcare Services
Description

Home healthcare services including blood collection, urine and stool sampling, genetic testing, MAPA and Holter monitoring, and vaccination, with insurance coverage available. For individual patients who prefer at-home care.

12Corporate Health Solutions (Occupational Health, Toxicology, Executive Check-ups, Corporate Vaccination)
CategoryCorporate Occupational Health Services
Description

Corporate health solutions including occupational health exams, toxicology testing, executive check-ups, and vaccination programs sold directly to enterprises for employee wellness. For corporate clients and HR/occupational health teams in Brazil.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1ONG Xingu+Catu
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Dasa partnered with indigenous healthcare NGO Xingu+Catu to provide pioneering cervical cancer prevention services for indigenous women in the Xingu region, demonstrating corporate social responsibility and healthcare access expansion.

dasa.com.br
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-11-01
Description

Dasa announced a 4-year strategic partnership with the Brazilian Olympic Committee (COB) to provide comprehensive healthcare for Brazilian sports teams preparing for the 2028 Olympics. The partnership encompasses diagnostic services, medical consultations, and specialized healthcare programs for athletes.

3Instituto Ekos Brasil
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Dasa became a supporter of Instituto Ekos Brasil and joined the Climate Commitment Program (Programa Compromisso com o Clima) to advance climate action. The partnership provides access to a digital platform for purchasing carbon credits from verified socioenvironmental projects, enabling the company to compensate its greenhouse gas emissions through high-integrity initiatives.

dasa.com.br
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Multi-company consortium including ACIF, CDL, ENGIE Brasil Energia, Sinduscon Grande Florianópolis, ACATE, Floripa Sustentável, ACM, FIESC, OAB/SC, and Intelbrás collaborated to combat COVID-19 in Greater Florianópolis region, providing free telemedicine, testing, and health referrals.

Strategic tierCoreTypeTechnology or Integration
Description

Filoo serves as the operational platform partner for Dasa +Saúde subscription card, providing the technological infrastructure for membership management, provider network coordination, and digital card services.

6Instituto de Ensino e Pesquisa Dasa (IEPD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dasa's education and research institute supporting academic and clinical research collaboration, with Dasa as sole sponsor until 2023. The institute advances real-world evidence studies submitted to regulatory bodies in cardiology, metabolic syndrome, neurology, infectious diseases, and oncology, including AI-driven health strategies.

dasa.com.br
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest clinical laboratory network in the United States, with comparable business model spanning routine diagnostics, advanced/esoteric testing, and employer health services. Useful global benchmark for Dasa's unit economics, digital strategy, and data-monetization roadmap.

TypeBroad incumbent
Description

Europe's largest medical diagnostics services provider, operating a pan-regional network of clinical labs and imaging centers. Comparable in consolidation strategy across regional brands and exposure to public-payer reimbursement dynamics.

3Hospital Israelita Albert Einstein
TypeBroad incumbent
Description

Top-tier Brazilian hospital system that operates its own diagnostic laboratory and outpatient imaging services. Competes for high-end physician referrals, executive check-up volume, and corporate health contracts in the premium segment.

TypeBroad incumbent
Description

Global leader in bioanalytical testing and clinical diagnostics, with a network of clinical labs and specialty testing capabilities. Comparable in scale, multi-brand acquisition model, and focus on specialty/advanced testing as a higher-margin growth lever.

TypeDirect peer
Description

Brazil's second-largest integrated diagnostic medicine company, with a comparable portfolio of clinical analysis, imaging, and specialized testing brands. Direct head-to-head competitor for the same physicians, patients, and corporate health contracts across major Brazilian metros.

6Hapvida NotreDame Intermédica
TypeBroad incumbent
Description

One of Brazil's largest vertically integrated health plan and hospital operators, with growing in-house diagnostic capability. Comparable in scale, vertical integration strategy, and focus on volume-based care delivery in Brazil.

TypeRegional player
Description

Elite São Paulo-based hospital system with in-house diagnostic and outpatient laboratory operations. Competes with Dasa in the high-end São Paulo market for complex diagnostics, executive check-ups, and physician referral volume.

TypeOthers
Description

Brazil's largest healthcare cooperative system, with hundreds of affiliated labs and diagnostic units across the country. Functions as both a customer (referral channel) and indirect competitor for the physician-referred exam volume that underpins Dasa's 350,000+ physician network.

TypeBroad incumbent
Description

Major US clinical lab and diagnostics services company with a similar mix of routine testing, specialty diagnostics, and corporate health solutions. Comparable on R&D-led specialty test development (analogous to Dasa Genômica) and B2B employer services.

TypeBroad incumbent
Description

Largest private hospital network in Brazil, increasingly integrating diagnostic services into its hospital footprint. Competes with Dasa in oncology, imaging, and integrated care delivery for both insured and corporate clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries59 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dasa

Diagnostic Medicine and Healthcare Servicesdasa.com.br

Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ units under 40+ brands and serving 20M+ patients and 350,000+ physicians annually across lab, imaging, hospital, oncology, and genomic services.

What Dasa does

Dasa operates Brazil's largest integrated diagnostic medicine network and is positioned as the largest laboratory network in Latin America. The company runs 850+ diagnostic units under 40+ regional brands (including Delboni, Lavoisier, Sérgio Franco, Bronstein, Alta Diagnósticos, and others) and processes more than 400 million examinations annually in partnership with 350,000+ physicians, serving over 20 million patients per year. Beyond diagnostics, the business spans hospital care (Hospital São Domingos, Hospital da Bahia, Hospital Paraná, Grupo São Camilo), oncology (Dasa Oncologia, Amo, Onco Centro, Onco Hematos), genomic medicine (Dasa Genômica), and care management (Dasa Gestão de Cuidados), with a digital patient platform (Nav Dasa) consolidating scheduling, teleconsultations, and medical history across all brands.

Dasa firmographics

Firmographics
Name
Dasa
Legal name
Dasa
Website
https://dasa.com.br
Company type
Public
Founded year
2023
Operating status
Operating
Headcount range
10,001+ employees
Short description
Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ units under 40+ brands and serving 20M+ patients and 350,000+ physicians annually across lab, imaging, hospital, oncology, and genomic services.
Ownership category
akta.pro rank

Dasa industry classification

Industry
Product category
Diagnostic Medicine and Healthcare Services
NAICS
Medical Laboratories (621511), Diagnostic Imaging Centers (621512)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Diagnostic medicine services
  • Clinical laboratory testing
  • Medical imaging diagnostics
  • Genomic testing services
  • Corporate occupational health

Where Dasa is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices3 records

Markets served

Dasa business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Diagnostic Services: Laboratory diagnostic services including clinical analysis, imaging, and genetic testing across 850+ units throughout Brazil.
  2. Hospital and Oncology Services: Hospital care and oncology treatment services with 15% revenue growth in 2023 compared to previous year.
  3. Dasa +Saúde Subscription Card: Annual subscription card offering discounts on consultations, exams, vaccines, and medications with monthly payment options (R$9.90-19.90/month).
  4. Corporate Health Solutions: B2B services including occupational health exams, toxicology testing, executive check-ups, and vaccination programs for corporate clients.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyBasic plan with essential health discounts
SubscriptionMonthlyPlus plan with enhanced discount benefits

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Dasa product offering

Product offering

Core offering

Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ laboratory and imaging units under 40+ regional brands that process over 400 million examinations annually. The company offers clinical laboratory tests, diagnostic imaging, genomic testing (Dasa Genômica), oncology care (Dasa Oncologia), hospital services, and corporate occupational health solutions, complemented by the Nav Dasa digital platform for appointments and teleconsultations.

Product overview

Dasa is Brazil's largest integrated healthcare network, operating as a platform combining multiple diagnostic medicine brands and healthcare services. The core offering includes the Dasa diagnostic medicine network with 850+ laboratory and imaging units, complemented by specialized verticals including Dasa Genômica (genomic testing), Dasa Oncologia (cancer care), and hospital/care management services. Digital access is provided through Nav Dasa platform for appointments and medical records, while the Cartão Dasa +Saúde membership program offers discounted healthcare services. Additional services include clinical research, medical education (Dasa Educa), vaccination programs, and home healthcare visits. The company operates through 40+ regional brands across Brazil including Delboni, Lavoisier, Sérgio Franco, Bronstein, and many others.

Differentiator

Problem solved

Functional benefit

Brands

  • Cartão Dasa +Saúde: A health benefits card offering discounts on consultations, exams, vaccines, and medications with annual subscription plans starting at R$9.90/month.

Products and services

  • Dasa - Rede de Medicina Diagnóstica Brazil's largest integrated diagnostic medicine network offering laboratory tests, imaging services, and clinical analysis across 850+ locations throughout Brazil, processing over 400 million tests annually in partnership with 350,000+ physicians. Serves individual patients and corporate clients with routine and specialized diagnostic services.
  • Nav Dasa
  • Dasa Genômica Specialized genomics laboratory focused on personalized medicine, offering genetic testing for diagnosis, prognosis, and treatment guidance across multiple medical specialties including oncology, endocrinology, and neurology. For physicians, patients, and clinical researchers.
  • Dasa Oncologia Oncology care service dedicated to ensuring each person in treatment receives appropriate and personalized care, providing comprehensive cancer treatment management. For cancer patients across Brazil.
  • Dasa Hospitais e Cuidados Integrados Hospital network and integrated care management company with multidisciplinary teams accompanying patients across all stages from prevention to treatment. Includes hospitals such as Hospital da Bahia, Hospital São Domingos, and Grupo São Camilo.
  • Cartão Dasa +Saúde Health benefits discount card offering real discounts on consultations, exams, vaccines, and medications with monthly subscriptions starting at R$9.90 (Basic) or R$19.90 (Plus), covering over 40 medical specialties with national reach. For individuals, families, and corporate clients seeking affordable healthcare access.
  • Dasa Pesquisa Clínica Clinical research division organized into three verticals with hundreds of professionals acting as investigators in medical research studies, with over 1,000 studies published by February 2024.
  • NAM – Núcleo de Assessoria Médica Medical advisory center providing support services for physicians including continuing education, clinical guidance, and practice management support. For partner physicians and medical specialists across Brazil.
  • Dasa Educa
  • Dasa Vacinas Vaccination services available for individual patients, physicians, and corporate clients, including home vaccination appointments. For individual patients, families, and corporate employee wellness programs.
  • Atendimento Domiciliar Home healthcare services including blood collection, urine and stool sampling, genetic testing, MAPA and Holter monitoring, and vaccination, with insurance coverage available. For individual patients who prefer at-home care.
  • Corporate Health Solutions (Occupational Health, Toxicology, Executive Check-ups, Corporate Vaccination) Corporate health solutions including occupational health exams, toxicology testing, executive check-ups, and vaccination programs sold directly to enterprises for employee wellness. For corporate clients and HR/occupational health teams in Brazil.

Quantifiable outcome

  • 20 million+ patients served annually
  • +3 more outcomes

Companies that use Dasa

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Dasa technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Dasa partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor, flagship and core.

  • ONG Xingu+CatuminorStrategic or Co-development Partner · 1 February 2026Dasa partnered with indigenous healthcare NGO Xingu+Catu to provide pioneering cervical cancer prevention services for indigenous women in the Xingu region, demonstrating corporate social responsibility and healthcare access expansion.
  • COB - Comitê Olímpico BrasileiroflagshipStrategic or Co-development Partner · 1 November 2025Dasa announced a 4-year strategic partnership with the Brazilian Olympic Committee (COB) to provide comprehensive healthcare for Brazilian sports teams preparing for the 2028 Olympics. The partnership encompasses diagnostic services, medical consultations, and specialized healthcare programs for athletes.
  • Instituto Ekos BrasilcoreStrategic or Co-development Partner · 1 January 2022Dasa became a supporter of Instituto Ekos Brasil and joined the Climate Commitment Program (Programa Compromisso com o Clima) to advance climate action. The partnership provides access to a digital platform for purchasing carbon credits from verified socioenvironmental projects, enabling the company to compensate its greenhouse gas emissions through high-integrity initiatives.
  • Aliança Pela Vida ConsortiumminorStrategic or Co-development Partner · 1 January 2021Multi-company consortium including ACIF, CDL, ENGIE Brasil Energia, Sinduscon Grande Florianópolis, ACATE, Floripa Sustentável, ACM, FIESC, OAB/SC, and Intelbrás collaborated to combat COVID-19 in Greater Florianópolis region, providing free telemedicine, testing, and health referrals.
  • FiloocoreTechnology or IntegrationFiloo serves as the operational platform partner for Dasa +Saúde subscription card, providing the technological infrastructure for membership management, provider network coordination, and digital card services.
  • Instituto de Ensino e Pesquisa Dasa (IEPD)coreStrategic or Co-development PartnerDasa's education and research institute supporting academic and clinical research collaboration, with Dasa as sole sponsor until 2023. The institute advances real-world evidence studies submitted to regulatory bodies in cardiology, metabolic syndrome, neurology, infectious diseases, and oncology, including AI-driven health strategies.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Dasa competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Largest clinical laboratory network in the United States, with comparable business model spanning routine diagnostics, advanced/esoteric testing, and employer health services. Useful global benchmark for Dasa's unit economics, digital strategy, and data-monetization roadmap.
  • SYNLAB Group: Europe's largest medical diagnostics services provider, operating a pan-regional network of clinical labs and imaging centers. Comparable in consolidation strategy across regional brands and exposure to public-payer reimbursement dynamics.
  • Hospital Israelita Albert Einstein: Top-tier Brazilian hospital system that operates its own diagnostic laboratory and outpatient imaging services. Competes for high-end physician referrals, executive check-up volume, and corporate health contracts in the premium segment.
  • Eurofins Scientific SE: Global leader in bioanalytical testing and clinical diagnostics, with a network of clinical labs and specialty testing capabilities. Comparable in scale, multi-brand acquisition model, and focus on specialty/advanced testing as a higher-margin growth lever.
  • Hapvida NotreDame Intermédica: One of Brazil's largest vertically integrated health plan and hospital operators, with growing in-house diagnostic capability. Comparable in scale, vertical integration strategy, and focus on volume-based care delivery in Brazil.
  • Laboratory Corporation of America (Labcorp Diagnostics): Major US clinical lab and diagnostics services company with a similar mix of routine testing, specialty diagnostics, and corporate health solutions. Comparable on R&D-led specialty test development (analogous to Dasa Genômica) and B2B employer services.
  • Rede D'Or São Luiz S.A. Largest private hospital network in Brazil, increasingly integrating diagnostic services into its hospital footprint. Competes with Dasa in oncology, imaging, and integrated care delivery for both insured and corporate clients.

Direct peers

  • Fleury S.A. Brazil's second-largest integrated diagnostic medicine company, with a comparable portfolio of clinical analysis, imaging, and specialized testing brands. Direct head-to-head competitor for the same physicians, patients, and corporate health contracts across major Brazilian metros.

Regional players

  • Hospital Sírio-Libanês: Elite São Paulo-based hospital system with in-house diagnostic and outpatient laboratory operations. Competes with Dasa in the high-end São Paulo market for complex diagnostics, executive check-ups, and physician referral volume.

Others

  • Unimed (Confederação Nacional das Cooperativas Médicas): Brazil's largest healthcare cooperative system, with hundreds of affiliated labs and diagnostic units across the country. Functions as both a customer (referral channel) and indirect competitor for the physician-referred exam volume that underpins Dasa's 350,000+ physician network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Dasa social profiles

Digital presence

Dasa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dasa leadership team

Management profile

Number of profiles

Profiles6 records

Dasa subsidiaries and ownership

Company hierarchy

Subsidiaries59 records

Dasa funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dasa M&A and investment

M&A and investment

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dasa

What does Dasa do?

Dasa is Brazil's largest integrated diagnostic medicine network, operating 850+ laboratory and imaging units under 40+ regional brands that process over 400 million examinations annually. The company offers clinical laboratory tests, diagnostic imaging, genomic testing (Dasa Genômica), oncology care (Dasa Oncologia), hospital services, and corporate occupational health solutions, complemented by the Nav Dasa digital platform for appointments and teleconsultations.

Is Dasa a public or private company?

Dasa is a public company. It is classified as public and is currently operating.

When was Dasa founded?

Dasa was founded in 2023. It employs 10,001+ people.

Where is Dasa based?

Dasa is headquartered in São Paulo, Brazil, in the Latin America region.

How does Dasa make money?

Four revenue lines are on record. Diagnostic Services are the primary driver. The others are hospital and Oncology Services, dasa +Saúde Subscription Card and corporate Health Solutions.

Who are Dasa's main competitors?

Broad incumbents on record are Quest Diagnostics, SYNLAB Group, Hospital Israelita Albert Einstein, Eurofins Scientific SE, Hapvida NotreDame Intermédica, Laboratory Corporation of America (Labcorp Diagnostics) and Rede D'Or São Luiz S.A.. Fleury S.A. is listed as a direct peer. Hospital Sírio-Libanês is listed as a regional player. Unimed (Confederação Nacional das Cooperativas Médicas) is listed as an others.

Does Dasa have an API?

No public API is recorded for Dasa.

What industry is Dasa in?

Dasa's product category is Diagnostic Medicine and Healthcare Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAHABAI, Imaging Informatics & Workflow (PACS/RIS/VNA). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InfoMoneyDasa (DASA3) dispara 20% após balanço com geração de caixa acima das expectativasDasa's shares rose 20% after Q3 2026 results, with net cash flow above expectations but operating margins below projections. Revenue was R$2.41B, EBITDA R$640M, and net profit from continuing operations was 56% above Morgan Stanley's estimate. Goldman Sachs and XP reiterated neutral and constructive views, citing high leverage.InfoMoneyDasa (DASA3) lucra R$ 173 mi no 3º tri, alta de 79%Dasa reported R$173 million in net profit for Q3 2026, up 78.7% year-over-year, with consolidated revenue of R$2.6 billion, down 9% due to deconsolidation of Ímpar. The company said revenue grew 8% on its current scope, and free cash flow fell 11.1% to R$369 million.InfoMoneyDasa (DASA3) cai 14% após UBS BB cortar recomendação e apontar pressão dos jurosDasa shares fell 14.43% to R$2.55 after UBS BB downgraded it to neutral and cut its price target to R$3.40. The bank estimates higher rates could cut Dasa's projected 2027 net profit by 6%, citing R$1.3B in 2028 debt maturities.pegnUm nocaute nas ações de saúde em bolsa; Dasa cai 13%Health stocks in Brazil fell after the second election round, with Dasa dropping 13% and UBS downgrading to neutral. The UBS report cites high interest rates and fiscal concerns, while Bradsaúde and Rede D'Or remain preferred. Investors await a fiscal plan and the November 4 Copom decision.InfoMoneyApós eleição, UBS vê risco de correção em Hapvida e DasaUBS sees Hapvida and Dasa as most exposed to a correction after Lula's re-election, citing interest-rate sensitivity. A 100-point rise in the 10-year rate would cut their fair value by 10-13%, while Bradesco Saúde is favored as defensive. The bank keeps price targets unchanged.pegnO interesse de Vorcaro, Quadrado e Tanure nas empresas de saúdeMessages from the Master Bank ex-bankers Daniel Vorcaro and Maurício Quadrado reveal their interest in health companies Oncoclínicas, Dasa, and Amil between 2023 and 2024, with conflicts with Nelson Tanure. The Master injected R$1.5 billion into Oncoclínicas, which was used to buy CDBs, and Tanure denied knowledge of the messages.StartupiCom apoio de legaltech, DASA digitaliza gestão contratual e reduz em 70% o tempo de resposta da área jurídicaDASA reduced its average contract response time from 10 to 3 days, a 70% cut, after implementing netLex's automation platform. The legal team handled about 4,500 contracts in Q1 2026, including over 1,300 in March, without expanding headcount. The solution aims to scale operations and improve legal efficiency.Investing.comEarnings call transcript: DASA Q2 2026 profit beat overshadowed by revenue miss By Investing.comBrazilian healthcare services company DASA reported a smaller-than-expected loss for Q2 2026, beating EPS estimates significantly while revenue fell short of Wall Street forecasts. The mixed results, combined with margin pressure and a still-leveraged balance sheet, caused the stock to drop sharply by 16.73% following the release. Management highlighted strong operational improvements, including positive free cash flow and EBITDA growth, but emphasized continued focus on deleveraging.InfoMoneyDasa (DASA3) reduz prejuízo para R$ 35 milhões no 2º trimestreDasa reported a reduced net loss of R$34.9 million for the second quarter, a significant improvement from the R$173.2 million loss in the same period last year, driven by operational efficiency gains and asset divestitures. Consolidated EBITDA rose 53% to R$446 million with margin expansion to 20.1%, while free cash flow generation improved to R$292 million compared to a consumption of R$18 million previously.Brazil JournalROUNDTABLE: A ciência da longevidade - Brazil JournalBrazil is experiencing rapid population aging, with the elderly demographic doubling in 25 years and a projected inversion of the age pyramid by 2030. Experts highlight that while genetics play a role, lifestyle factors are crucial for healthy longevity, prompting calls for updated public and private healthcare systems. Dasa executive Leonardo Vedolin notes that technology, including genomics and AI, will increasingly support medical longevity efforts.